NiSource Operating Cash Flow decreased by 37.9% to $442.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 35.6%, from $686.40M to $442.30M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 18.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $254.70M | $236.30M | $278.60M | $579.80M | $327.40M | $129.00M | $373.20M | $683.40M | $507.60M | $344.90M | $399.20M | $456.20M | $445.50M | $340.00M | $539.80M | $686.40M | $495.40M | $467.90M | $712.60M | $442.30M |
| QoQ Change | — | -7.2% | +17.9% | +108.1% | -43.5% | -60.6% | +189.3% | +83.1% | -25.7% | -32.1% | +15.7% | +14.3% | -2.3% | -23.7% | +58.8% | +27.2% | -27.8% | -5.6% | +52.3% | -37.9% |
| YoY Change | — | — | — | — | +28.5% | -45.4% | +34.0% | +17.9% | +55.0% | +167.4% | +7.0% | -33.2% | -12.2% | -1.4% | +35.2% | +50.5% | +11.2% | +37.6% | +32.0% | -35.6% |